Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
73.42
-0.02 (-0.03%)
Apr 3, 2025, 3:58 PM EDT - Market open
Insmed Employees
Insmed had 1,271 employees as of December 31, 2024. The number of employees increased by 359 or 39.36% compared to the previous year.
Employees
1,271
Change (1Y)
359
Growth (1Y)
39.36%
Revenue / Employee
$286,158
Profits / Employee
-$718,939
Market Cap
13.29B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,271 | 359 | 39.36% |
Dec 31, 2023 | 912 | 176 | 23.91% |
Dec 31, 2022 | 736 | 123 | 20.07% |
Dec 31, 2021 | 613 | 92 | 17.66% |
Dec 31, 2020 | 521 | 86 | 19.77% |
Dec 31, 2019 | 435 | 62 | 16.62% |
Dec 31, 2018 | 373 | 159 | 74.30% |
Dec 31, 2017 | 214 | 53 | 32.92% |
Dec 31, 2016 | 161 | 36 | 28.80% |
Dec 31, 2015 | 125 | 36 | 40.45% |
Dec 31, 2014 | 89 | 28 | 45.90% |
Dec 31, 2013 | 61 | 20 | 48.78% |
Dec 31, 2012 | 41 | -1 | -2.38% |
Dec 31, 2011 | 42 | 2 | 5.00% |
Dec 31, 2010 | 40 | 25 | 166.67% |
Dec 31, 2009 | 15 | -82 | -84.54% |
Dec 31, 2008 | 97 | 3 | 3.19% |
Dec 31, 2007 | 94 | -63 | -40.13% |
Dec 31, 2006 | 157 | 72 | 84.71% |
Dec 31, 2005 | 85 | 30 | 54.55% |
Dec 31, 2004 | 55 | 35 | 175.00% |
Dec 31, 2003 | 20 | -3 | -13.04% |
Dec 31, 2002 | 23 | -37 | -61.67% |
Dec 31, 2001 | 60 | 20 | 50.00% |
Dec 31, 2000 | 40 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
INSM News
- 7 days ago - Biotech stocks have been hit hard. Why they're a great value now. - Market Watch
- 9 days ago - Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference - PRNewsWire
- 24 days ago - Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PRNewsWire
- 5 weeks ago - Lung Disease-Focused Insmed 'Is An Attractive Midcap Biotech,' Analyst Says - Benzinga
- 5 weeks ago - Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis - PRNewsWire
- 6 weeks ago - Insmed Incorporated (INSM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Insmed Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 7 weeks ago - Insmed To Present at March 2025 Investor Conferences - PRNewsWire